Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Endoscopy. 2010 Jul;42(7):546-56. doi: 10.1055/s-0029-1244127. Epub 2010 Apr 29.

Utilization of lower gastrointestinal endoscopy and fecal occult blood test in 11 European countries: evidence from the Survey of Health, Aging and Retirement in Europe (SHARE).

Author information

  • 1Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Abstract

BACKGROUND AND STUDY AIMS:

Lower gastrointestinal endoscopy (sigmoidoscopy and colonoscopy) and the fecal occult blood test (FOBT) are thought to impact on colorectal cancer incidence and mortality. We aimed to estimate prevalences and to investigate potential determinants of utilization of these procedures in the general population across Europe.

METHODS:

Data from the Survey of Health, Aging, and Retirement in Europe (SHARE) were used. Prevalences of lower gastrointestinal endoscopy and FOBT utilization among adults aged >or= 50 years in 11 countries (Austria, Belgium, Denmark, France, Germany, Greece, Italy, The Netherlands, Spain, Sweden, and Switzerland) were estimated. Potential determinants of utilization of the tests were analyzed by multivariate logistic regression.

RESULTS:

Overall, 18 139 individuals were included. The proportion of respondents reporting lower gastrointestinal endoscopy and FOBT utilization within the previous 10 years ranged from 6.1 % (95 % confidence interval [CI] 4.7 - 6.9; Greece) to 25.1 % (95 %CI 22.1 - 27.2; France) and from 4.1 % (95 %CI 3.2 - 4.9; The Netherlands) to 61.1 % (95 %CI 58.6 - 63.6; Austria), respectively. Observed sex differences were highest in France and Germany; however results were only partly statistically significant. Country, age, education, income, marital status (FOBT only), location of main residence (FOBT only), smoking history, and self-perceived health status were statistically significant predictors of test utilization.

CONCLUSION:

Prevalences of lower gastrointestinal endoscopy and FOBT utilization vary widely across European countries. They need to be considered in the interpretation of cross-national differences and time trends in colorectal cancer incidence and mortality, and in the design and evaluation of colorectal cancer screening programs.

Comment in

PMID:
20432204
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Georg Thieme Verlag Stuttgart, New York
    Loading ...
    Write to the Help Desk